Asked by: Baroness Berger (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will publish the civil service briefing entitled Introduction to no deal adult social care planning, as reported by The Guardian on 26 February 2019.
Answered by Caroline Dinenage
The Department does not comment on leaked documents.
Information on a ‘no deal’ European Union exit planning for adult social care is available on GOV.UK at the following links:
Asked by: Baroness Berger (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what (a) briefings and (b) advice his Department has provided to social care providers on the potential effect on that sector of the UK leaving the EU without a deal.
Answered by Caroline Dinenage
Ministers and the Department have written to social care providers and commissioners about the Government's preparations for a potential ‘no deal’ European Union exit, and about actions that providers and commissioners of social care services should take to prepare for, and manage, the risks of a ‘no deal’ EU exit scenario. This correspondence and guidance is available online on GOV.UK.
Asked by: Baroness Berger (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of local authorities' capacity to take over the social care of people if the existing providers of that care fail.
Answered by Caroline Dinenage
If an adult social care provider’s business fails, local authorities have a statutory duty, under the Care Act 2014, to meet people’s care and support needs temporarily until suitable, alternative provision can be arranged.
The Government is working with local authorities and providers to ensure that adult social care services continue as normal. This includes ensuring that effective and up-to-date contingency plans are in place.
Asked by: Baroness Berger (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 February 2019 to Question 220201 on Hospitals: Transport, by what date all of the new mental health vehicles to reduce inappropriate use of ambulances and police vehicles will be in place.
Answered by Jackie Doyle-Price
NHS England will be setting out more detailed information about implementation of the NHS Long Term Plan in the spring. This will include more detail on funding and ambitions over the first five years of the plan, including the ambitions to improve the capacity of the ambulance services to respond to mental health needs.
The Department has no plans to make an assessment of the effect of police transportation on the recovery and health of people in mental health crisis.
Asked by: Baroness Berger (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12th February 2019 to Question 220198 on Hospitals: Transport, whether his Department has plans to make an assessment of the effect of police transportation on the recovery and health of people in mental health crisis.
Answered by Jackie Doyle-Price
NHS England will be setting out more detailed information about implementation of the NHS Long Term Plan in the spring. This will include more detail on funding and ambitions over the first five years of the plan, including the ambitions to improve the capacity of the ambulance services to respond to mental health needs.
The Department has no plans to make an assessment of the effect of police transportation on the recovery and health of people in mental health crisis.
Asked by: Baroness Berger (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference article entitled, How will Brexit affect health services in the UK? An updated evaluation, published in the Lancet on 27 February 2019,when his Department plans to publish the (a) medicines and (b) medical devices for which his Department has supply concerns in the event that the UK leaves the EU without a deal.
Answered by Stephen Hammond
The Department is working closely with trade bodies, product suppliers, the health and care system in England, the devolved administrations and Crown Dependencies, to make detailed plans to ensure the continuation of the supply of medical products to the whole of the United Kingdom in the event of a ‘no deal’ European Union exit.
We have also assessed contract risks associated with potential EU exit in the broader National Health Service and within the devolved administrations, and are working with suppliers to ensure adequate mitigations are in place for non-clinical goods and services (e.g. hospital food, laundry, IT contracts etc).
The key risk to supply is reduced traffic flow at the short straits crossing (i.e. between Calais and Dover or Folkestone), which is where the majority of medicines and other medical products imported from the EU/European Economic Area (EEA) come from. Many companies across all sectors, have already taken measures to protect their own supply chain to avoid the possible delays at the Dover Straits. The Department for Transport has also procured additional ‘roll on roll off’ freight capacity equivalent of around an extra 2,200 heavy goods vehicle per week to help companies in importing medicines and medical products into the UK.
The Government recognises the vital importance of medicines and medical products, including insulin, and is working to ensure that there is sufficient roll-on, roll-off freight capacity to enable these vital products to continue to move freely in to the UK.
The Government has agreed that medicines and medical products will be prioritised on these alternative routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.
In August 2018, the Department asked suppliers to confirm arrangements in respect of prescription-only and pharmacy medicines that come from or via the EU/EEEA. Company responses have provided the Department with an indication of industry’s ability and preparedness to stockpile six weeks’ worth of additional supply of each of the in-scope medicines in the UK ahead of 29 March 2019.
Since then, we have continued to receive very good engagement and are working closely with industry on a product-by-product basis. Companies share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.
Asked by: Baroness Berger (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to tarticle entitled, How will Brexit affect health services in the UK? An updated evaluation’, published in the Lancet on 27 February 2019, what steps his Department is taking to ensure access to insulin in the event that the UK leaves the EU (a) with and (b) without a withdrawal agreement.
Answered by Stephen Hammond
The Department is working closely with trade bodies, product suppliers, the health and care system in England, the devolved administrations and Crown Dependencies, to make detailed plans to ensure the continuation of the supply of medical products to the whole of the United Kingdom in the event of a ‘no deal’ European Union exit.
We have also assessed contract risks associated with potential EU exit in the broader National Health Service and within the devolved administrations, and are working with suppliers to ensure adequate mitigations are in place for non-clinical goods and services (e.g. hospital food, laundry, IT contracts etc).
The key risk to supply is reduced traffic flow at the short straits crossing (i.e. between Calais and Dover or Folkestone), which is where the majority of medicines and other medical products imported from the EU/European Economic Area (EEA) come from. Many companies across all sectors, have already taken measures to protect their own supply chain to avoid the possible delays at the Dover Straits. The Department for Transport has also procured additional ‘roll on roll off’ freight capacity equivalent of around an extra 2,200 heavy goods vehicle per week to help companies in importing medicines and medical products into the UK.
The Government recognises the vital importance of medicines and medical products, including insulin, and is working to ensure that there is sufficient roll-on, roll-off freight capacity to enable these vital products to continue to move freely in to the UK.
The Government has agreed that medicines and medical products will be prioritised on these alternative routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.
In August 2018, the Department asked suppliers to confirm arrangements in respect of prescription-only and pharmacy medicines that come from or via the EU/EEEA. Company responses have provided the Department with an indication of industry’s ability and preparedness to stockpile six weeks’ worth of additional supply of each of the in-scope medicines in the UK ahead of 29 March 2019.
Since then, we have continued to receive very good engagement and are working closely with industry on a product-by-product basis. Companies share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.
Asked by: Baroness Berger (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the article entitled, How will Brexit affect health services in the UK? An updated evaluation, published on 27 February 2019, whether his Department’s stockpiling contingency plans will ensure medicinal supplies are secured in the long term after the UK leaves the EU.
Answered by Stephen Hammond
The Department is working closely with trade bodies, product suppliers, the health and care system in England, the devolved administrations and Crown Dependencies, to make detailed plans to ensure the continuation of the supply of medical products to the whole of the United Kingdom in the event of a ‘no deal’ European Union exit.
We have also assessed contract risks associated with potential EU exit in the broader National Health Service and within the devolved administrations, and are working with suppliers to ensure adequate mitigations are in place for non-clinical goods and services (e.g. hospital food, laundry, IT contracts etc).
The key risk to supply is reduced traffic flow at the short straits crossing (i.e. between Calais and Dover or Folkestone), which is where the majority of medicines and other medical products imported from the EU/European Economic Area (EEA) come from. Many companies across all sectors, have already taken measures to protect their own supply chain to avoid the possible delays at the Dover Straits. The Department for Transport has also procured additional ‘roll on roll off’ freight capacity equivalent of around an extra 2,200 heavy goods vehicle per week to help companies in importing medicines and medical products into the UK.
The Government recognises the vital importance of medicines and medical products, including insulin, and is working to ensure that there is sufficient roll-on, roll-off freight capacity to enable these vital products to continue to move freely in to the UK.
The Government has agreed that medicines and medical products will be prioritised on these alternative routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.
In August 2018, the Department asked suppliers to confirm arrangements in respect of prescription-only and pharmacy medicines that come from or via the EU/EEEA. Company responses have provided the Department with an indication of industry’s ability and preparedness to stockpile six weeks’ worth of additional supply of each of the in-scope medicines in the UK ahead of 29 March 2019.
Since then, we have continued to receive very good engagement and are working closely with industry on a product-by-product basis. Companies share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.
Asked by: Baroness Berger (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what contingency plans his Department has in place to ensure that reciprocal healthcare arrangements stay in place for UK citizens living in European countries following the UK leaving the EU (a) with and (b) without an agreement.
Answered by Stephen Hammond
The United Kingdom Government appreciates the importance of retaining reciprocal healthcare arrangements with the European Union and has been clear in the negotiations that it wants to protect the rights of UK citizens in the EU. Extensive work to prepare for a ‘no deal’ scenario, including contingency planning, has been under way for over two years and we are taking necessary steps to ensure the country continues to operate smoothly from the day we leave.
Subject to the Withdrawal Agreement being agreed by Parliament, during the implementation period the current rules on reciprocal healthcare will continue until December 2020. The rights of UK nationals living in the EU, and who fall within the scope of the Withdrawal Agreement, will continue to be protected after December 2020, for as long as these individuals remain in scope of the Withdrawal Agreement. This includes state pensioners already benefiting from that cover.
In the event that the UK exits the EU without a deal, EU citizens resident in the UK by 29 March 2019 will be able to stay and continue to access in country benefits and services, including healthcare, on broadly the same terms as now. This demonstrates the UK Government’s ongoing commitment to citizens and removes any ambiguity over their future. We are engaging with EU counterparts to urge them to make the same commitment to protect the rights of UK nationals in the EU.
The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual, including retired UK citizen living in other EU Member States, will face sudden changes to their healthcare cover.
The Government has published updated advice for UK persons resident in countries in the European Economic Area as well as for those wishing to travel to such countries with specific information on potential changes to access to reciprocal healthcare and precautions they may wish to take in the event of a ‘no deal’ scenario.
General information is available on the GOV.UK website and country-specific advice can be found under the relevant sections of NHS.UK as well. This includes guidance for UK citizens living in European countries and suggestions on alternative arrangements they may wish to make, should existing arrangements such as the European Health Insurance Card scheme cease, which appears as a section under the profile of each individual country.
The information provided on these pages will be updated in light of new developments and changing circumstances.
Asked by: Baroness Berger (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans his Department has to ensure retired UK citizen living in other EU Member States will have access to healthcare in the event that the UK leaves the EU without a deal.
Answered by Stephen Hammond
The United Kingdom Government appreciates the importance of retaining reciprocal healthcare arrangements with the European Union and has been clear in the negotiations that it wants to protect the rights of UK citizens in the EU. Extensive work to prepare for a ‘no deal’ scenario, including contingency planning, has been under way for over two years and we are taking necessary steps to ensure the country continues to operate smoothly from the day we leave.
Subject to the Withdrawal Agreement being agreed by Parliament, during the implementation period the current rules on reciprocal healthcare will continue until December 2020. The rights of UK nationals living in the EU, and who fall within the scope of the Withdrawal Agreement, will continue to be protected after December 2020, for as long as these individuals remain in scope of the Withdrawal Agreement. This includes state pensioners already benefiting from that cover.
In the event that the UK exits the EU without a deal, EU citizens resident in the UK by 29 March 2019 will be able to stay and continue to access in country benefits and services, including healthcare, on broadly the same terms as now. This demonstrates the UK Government’s ongoing commitment to citizens and removes any ambiguity over their future. We are engaging with EU counterparts to urge them to make the same commitment to protect the rights of UK nationals in the EU.
The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual, including retired UK citizen living in other EU Member States, will face sudden changes to their healthcare cover.
The Government has published updated advice for UK persons resident in countries in the European Economic Area as well as for those wishing to travel to such countries with specific information on potential changes to access to reciprocal healthcare and precautions they may wish to take in the event of a ‘no deal’ scenario.
General information is available on the GOV.UK website and country-specific advice can be found under the relevant sections of NHS.UK as well. This includes guidance for retired UK citizens living in other EU Member States and suggestions on alternative arrangements they may wish to make, should existing arrangements such as the European Health Insurance Card scheme cease, which appears as a section under the profile of each individual country.
The information provided on these pages will be updated in light of new developments and changing circumstances.